Organon & Co.
OGN
$6.37
$0.030.39%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.92% | -1.69% | -1.02% | -0.84% | 2.24% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.92% | -1.69% | -1.02% | -0.84% | 2.24% |
| Cost of Revenue | 5.92% | 4.75% | 3.81% | 3.31% | 6.88% |
| Gross Profit | -9.31% | -6.29% | -4.44% | -3.71% | -0.88% |
| SG&A Expenses | -1.72% | 4.17% | -2.18% | -3.82% | -3.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.53% | 2.67% | -0.12% | -0.83% | 1.07% |
| Operating Income | -14.23% | -14.96% | -4.14% | -0.84% | 6.25% |
| Income Before Tax | -47.34% | -10.23% | 1.68% | -0.30% | 19.91% |
| Income Tax Expenses | 517.54% | 138.73% | 90.14% | 79.09% | 83.71% |
| Earnings from Continuing Operations | -78.36% | -61.49% | -30.00% | -28.37% | -15.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -78.36% | -61.49% | -30.00% | -28.37% | -15.54% |
| EBIT | -14.23% | -14.96% | -4.14% | -0.84% | 6.25% |
| EBITDA | -7.27% | -8.41% | 0.48% | 2.39% | 7.84% |
| EPS Basic | -78.50% | -61.89% | -30.57% | -28.91% | -16.11% |
| Normalized Basic EPS | -18.50% | -21.46% | -4.43% | 1.56% | 12.34% |
| EPS Diluted | -78.63% | -62.10% | -31.03% | -29.67% | -16.81% |
| Normalized Diluted EPS | -18.20% | -21.35% | -4.57% | 1.25% | 11.90% |
| Average Basic Shares Outstanding | 0.95% | 0.91% | 0.86% | 0.79% | 0.71% |
| Average Diluted Shares Outstanding | 0.52% | 0.81% | 1.06% | 1.17% | 1.13% |
| Dividend Per Share | -69.64% | -46.43% | -23.21% | 0.00% | 0.00% |
| Payout Ratio | 0.37% | 0.39% | 0.11% | 0.43% | 0.20% |